Concert Genetics
An experienced software and information services executive, Rob has a passion for building world class companies that use technology to transform entire industries. As CEO of Concert Genetics, Rob is expanding the company’s offerings to advance precision medicine by providing the digital infrastructure for reliable and efficient management of genetic testing.
Prior to Concert Genetics, Rob led cognitive computing company Digital Reasoning as President and Chief Operating Officer, guiding the business through an expansion into financial services and healthcare markets, as well as securing multiple rounds of capital from strategic investors. Prior to Digital Reasoning, Rob held executive positions in Mexico, Canada and the United States with the information services leader LexisNexis. At LexisNexis, Rob oversaw numerous acquisitions as part of the acceleration of the company’s software strategy.
Rob earned his bachelor’s degree in history from Princeton University and his Master of Business Administration from Harvard Business School.
This person is not in any offices
Concert Genetics
Genetic testing is the lynchpin of precision medicine, but the rapid pace of change in the market makes it enormously complex. Today, there are more than 75,000 unique genetic testing products on the market, and an average of 10 new products are added each day. This growth confounds the processes through which tests are ordered, resulted, billed and reimbursed. Founded in 2010 with a vision to simplify this complexity, Concert Genetics (formerly NextGxDx, Inc.) launched as a healthcare technology company dedicated to streamlining the genetic test selection, ordering, payment and management for clinicians, hospitals, laboratories and health plans. With a leading team of clinicians, researchers, data scientists and software engineers, Concert Genetics launched its proprietary solutions to enable end-to-end genetic testing management, from searching and comparing testing products, to tracking orders and results, to payment integrity and forecasting trends in pricing and utilization. Today, stakeholders across the healthcare system turn to Concert Genetics to better understand and navigate the rapid transformation to precision medicine that is underway.